This session provides an update on diabetes mellitus and its related complications. Pathophysiology and pharmacotherapy relative to medical-surgical nursing practice is also shared, as well as information about the newer incretin-based therapies used in the treatment of DM.
Contact hours available until 9/29/2015.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Conflict of Interest Disclosure: Speaker(s) have no disclosures to declare.
Planning Committee members have no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
This educational activity has been co-provided by Anthony J. Jannetti, Inc. and Academy of Medical-Surgical Nurses.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC-COA).
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered nursing, Provider Number, CEP 5387.
Review physiology of glucose homeostasis.
Review the diagnostic criteria for diabetes mellitus.
Describe the pathophysiology of diabetes, including macrovascular, microvascular, and neuropathic alterations.
Review the therapeutic regimen for treatment of diabetes, such as insulin and traditional medications.
Discuss the role of the newer incretin-based therapies in the treatment of diabetes.
PhD, CRNP, ANP-BC,
Critical Care Clinical Nurse Specialist and Manager,
Roxborough Memorial Hospital
You must be logged in and own this session in order to